PLoS Biology features works of exceptional significance, originality, and relevance in all areas of biological science, from molecules to ecosystems, including works at the interface of other disciplines, such as chemistry, medicine, and mathematics. Our audience is the international scientific community as well as educators, policy makers, patient advocacy groups, and interested members of the public around the world.
PLoS Computational Biology features works of exceptional significance that further our understanding of living systems at all scales—from molecules and cells, to patient populations and ecosystems—through the application of computational methods. Readers include life and computational scientists, who can take the important findings presented here to the next level of discovery.Research articles that primarily describe new methods and offer only limited biological insight will be considered only in those exceptional instances in which the method is expected to significantly impact the field of computational biology, typically making substantial breakthroughs in areas of demonstrated importance. Research articles modeling aspects of biological systems should demonstrate both scientific novelty and profound new biological insights. Research articles describing improved or routine methods, models, software, and databases will not be considered by PLoS Computational Biology, and may be more appropriate for PLoS ONE.Generally, reliability and significance of biological discovery are validated and enriched by experimental studies. Experimental validation is not required for publication, however, nor does experimental validation of a modest biological discovery render a manuscript suitable for PLoS Computational Biology.For all submissions, authors must clearly provide detail, data, and software to ensure readers' ability to reproduce the models, methods, and results.Authors unsure of whether their work is within the scope of the journal should submit a presubmission inquiry.
Genetics and genomics research has grown at a bewildering pace in the past 15 years. The techniques of these fields are being applied to a wealth of biological questions and experimental systems. PLoS Genetics reflects the full breadth and interdisciplinary nature of this research by publishing outstanding original contributions in all areas of biology.PLoS Genetics publishes human studies, as well as research on model organisms—from mice and flies, to plants and bacteria. Our emphasis is on studies of broad interest that provide significant mechanistic insight into a biological process or processes. Topics include (but are not limited to) gene discovery and function, population genetics, genome projects, comparative and functional genomics, medical genetics, disease biology, evolution, gene expression, complex traits, chromosome biology, and epigenetics.Please refer to our Author Guidelines and Frequently Asked Questions when you are preparing manuscripts for submission. If you are unsure whether your work is suitable for PLoS Genetics, you can send a Presubmission Inquiry.
An influential venue for research and commentary on the major challenges to human health worldwide, PLOS Medicine publishes articles of general interest on biomedical, environmental, social and political determinants of health. The journal emphasizes work that advances clinical practice, health policy or pathophysiological understanding to benefit health in a variety of settings.
PLOS Medicine is committed to upholding the highest ethical standards in medical publishing, including the management and disclosure of conflicts of interest in reporting, review, and publication; transparency in the review and publication process; data sharing and reuse of work; authors' retention of copyright; Open Access publication with no restrictions on availability and dissemination; and avoiding the conflicts of interest presented by advertising for drugs and medical devices and exclusive sale of reprints.
PLOS Medicine publishes articles relevant to clinicians, policymakers, and researchers across a range of settings that address the major biological, environmental, social, and political determinants of health. The editors make decisions on submissions based upon their potential to directly and substantially inform clinical practice or health policy, and their relevance to our international audience.
Articles given highest priority for publication are those that address conditions or risk factors that cause the greatest losses in years of healthy life and quality of life worldwide.
PLOS Medicine also seeks to publish articles in the area of translational medicine that provide substantial, novel mechanistic insights into disease processes, with potential implications for clinical care. Additionally PLOS Medicine considers articles on topics relating to the integrity and ethics of the research enterprise; the practice of medicine; and the application of research to practice to fall within its scope.
PLOS Mental Health, is a new open-access journal for research that leads to healthier lives by improving discussion, interdisciplinary collaboration and understanding of all aspects of mental health in individual, societal, and community contexts.
PLOS Mental Health is an inclusive, peer-reviewed, journal that aims to address challenges and gaps in the field of mental health research, treatment, and care in ways that put the lived experience of individuals and communities first. By uniting all stakeholders through rigorous, open research, and increased visibility of the experiences of individuals and societies we aim to serve, we can further understanding, discussion, and action for mental health on a broader scale.
PLOS Neglected Tropical Diseases is devoted to the pathology, epidemiology, treatment, control, and prevention of the NTDs, as well as public policy relevant to this group of diseases.The NTDs are defined as a group of poverty-promoting chronic infectious diseases, which primarily occur in rural areas and poor urban areas of low-income and middle-income countries. They are poverty-promoting because of their impact on child health and development, pregnancy, and worker productivity, as well as their stigmatizing features.To see which diseases are included in the journal, please read the detailed scope.
PLOS ONE welcomes original research submissions from the natural sciences, medical research, engineering, as well as the related social sciences and humanities, including:
Primary research that contributes to the base of scientific knowledge, including interdisciplinary, replication studies, and negative or null results.
Systematic reviews whose methods ensure the comprehensive and unbiased sampling of existing literature.
Submissions describing methods, software, databases, or other tools that meet the journal’s criteria for utility, validation and availability.
Qualitative research that adheres to appropriate study design and reporting guidelines.
Protocols, including Lab Protocols that describe verified methodologies and Study Protocols that describe detailed plans for research projects.
Bacteria, fungi, parasites, prions and viruses cause a plethora of diseases that have important medical, agricultural, and economic consequences. Moreover, the study of microbes continues to provide novel insights into such fundamental processes as the molecular basis of cellular and organismal function. PLoS Pathogens reflects the full breadth of research in these areas by publishing outstanding original articles that significantly advance the understanding of pathogens and how they interact with their host organisms. Topics include (but are not limited to) adaptive and innate immune defenses as well as pathogen countermeasures, emerging pathogens, evolution, genomics and gene regulation, model host organisms, pathogen-cell biology, pathogenesis, prions, proteomics and signal transduction, rational vaccine design, structural biology, and virulence factors.PLoS Pathogens will consider studies that provide fundamental new understanding of the pathogen or pathogenic mechanisms. The journal will not consider purely descriptive studies, such as those that solely identify a new genomic sequence of a related pathogen or a series of related pathogens, the isolation of pathogen variants, or a new strain or type based only on sequence analysis. Such studies, as well as correlative studies of host and pathogen genotypes, would be considered if they use further experiments to test an idea or validate a mechanistic model, or to provide a clear set of novel conclusions that derive from the data.
PM&R is the official scientific journal of the American Academy of Physical Medicine and Rehabilitation (AAPM&R). It is a monthly, peer reviewed, scholarly publication. It aims to be an internationally leading journal that advances education and impacts the specialty of physical medicine and rehabilitation through the timely delivery of clinically relevant and evidence-based research and review information. Contributions from all parts of the world and from all types of professions in rehabilitation are therefore encouraged.Topics covered include acute and chronic musculoskeletal disorders and pain, neurologic conditions involving the central and peripheral nervous systems, rehabilitation of impairments associated with disabilities in adults and children, and neurophysiology and electrodiagnosis. PM&R emphasizes principles of injury, function, and rehabilitation, and is designed to be relevant to practitioners and researchers in a variety of medical and surgical specialties and rehabilitation disciplines including allied health.The content of PM&R includes articles that are contemporary and important to both research and clinical practice. The various sections of the journal include original research such as clinical trials, outcomes studies, and clinically relevant translational science; reviews (narrative and analytical); case presentations; point/counterpoint debates; ethical/legal topics; practice management updates; statistical themes; editorial and opinion pieces; images; clinical pearls; emerging issues; and letters to the editor.